Drug Information

Drug General Information
Drug ID
D08UML
Former ID
DNC013732
Drug Name
1-(Butan-2-ylidene)thiosemicarbazide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529513]
Formula
C5H11N3S
Canonical SMILES
CCC(=NNC(=S)N)C
InChI
1S/C5H11N3S/c1-3-4(2)7-8-5(6)9/h3H2,1-2H3,(H3,6,8,9)/b7-4-
InChIKey
NCQXVINEPVAIDB-DAXSKMNVSA-N
PubChem Compound ID
5363036
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [529513]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 529513Eur J Med Chem. 2009 Apr;44(4):1773-8. Epub 2008 Apr 27.A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.
Ref 529513Eur J Med Chem. 2009 Apr;44(4):1773-8. Epub 2008 Apr 27.A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.